Skip to main content

AI assistant

Sign in to chat with this filing

The assistant answers questions, extracts KPIs, and summarises risk factors directly from the filing text.

IDEXX LABORATORIES INC /DE Director's Dealing 2016

Feb 25, 2016

30016_dirs_2016-02-25_42af23df-8cf5-4752-a762-ae1bef19b277.zip

Director's Dealing

Open in viewer

Opens in your device viewer

SEC Form 4 — Statement of Changes in Beneficial Ownership

Issuer: IDEXX LABORATORIES INC /DE (IDXX)
CIK: 0000874716
Period of Report: 2016-02-17

Reporting Person: SZOSTAK M ANNE (Director)

Non-Derivative Transactions

Date Security Code Shares Price A/D Holdings After Ownership
2016-02-17 Common Stock P 2000 $69.9405 Acquired 8816 Indirect

Holdings (Non-Derivative)

Security Shares Ownership
Common Stock 584 Direct
Common Stock 6600 Indirect

Footnotes

F1: The purchase price reported reflects the weighted average purchase price of multiple transactions on the reported date at prices that ranged from $69.890 to $69.980, inclusive. The reporting person hereby undertakes to provide upon request to SEC staff, the issuer or a security holder of the issuer, full information regarding the number of shares purchased at each separate price within the range.